[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100541769":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":29,"centralContacts":33,"locations":42,"responsibleParty":61,"collaborators":29,"id":64,"slug":29,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":29,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":45,"whyStopped":29,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"University Hospital, Gentofte, Copenhagen","OTHER",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"Placebo","PLACEBO_COMPARATOR","Infusion of placebo",[13],"Other: Placebo",{"label":15,"type":16,"description":17,"interventionNames":18},"Oxytocin 0.1 IU\u002Fmin","EXPERIMENTAL","Infusion of oxytocin 0.1 IU\u002Fmin",[19],"Drug: Oxytocin",{"label":21,"type":16,"description":22,"interventionNames":23},"Oxytocin 0.2 IU\u002Fmin","Infusion of oxytocin 0.2 IU\u002Fmin",[19],[25,30],{"type":26,"name":27,"description":27,"armGroupLabels":28,"otherNames":29},"DRUG","Oxytocin",[15,21],null,{"type":6,"name":9,"description":31,"armGroupLabels":32,"otherNames":29},"Saline",[9],[34,39],{"name":35,"role":36,"phone":37,"phoneExt":29,"email":38},"Vivian Kliim-Hansen, MD","CONTACT","+4524476875","vivian.kliim-hansen@regionh.dk",{"name":40,"role":36,"phone":29,"phoneExt":29,"email":41},"Filip Krag Knop","filip.krag.knop.01@regionh.dk",[43],{"facility":44,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"Center for Clinical Metabolic Research, Gentofte Hospital","RECRUITING","Hellerup","Capital Region","2900","Denmark","DK",{"type":52,"coordinates":53},"Point",[54,55],12.57093,55.73204,{"lat":55,"lon":54},[58],{"name":59,"role":36,"phone":60,"phoneExt":29,"email":41},"Filip K Knop, MD, PhD","004538674266",{"type":62,"investigatorFullName":40,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":29,"oldOrganization":29},"PRINCIPAL_INVESTIGATOR","Professor","100541769",false,"NCT06334172","The Role of Oxytocin in Regulating Blood Glucose","GLOXY-1","Inclusion Criteria:\n\n* BMI 19-25 kg\u002Fm2\n\nExclusion Criteria:\n\n* Diabetes\n* Heart-, liver or kidney disease\n* More than 14 units of alcohol weekly, or drug abuse\n* Smoking or any kind of nicotine products\n* Alanin aminotransferase (ALAT) ≥ 2 × normal range\n* Estimated glomerular filtration rate (eGFR) \\\u003C 60 ml\u002Fmin\u002F1,73m2 or creatinine above normal range\n* Blood pressure \\> 140\u002F90\n* Hemoglobin \\\u003C normal range\n* Corrected QT Interval (Qtc) \\>0,45 sec. at electrocardiogram (ECG) at screening\n* Known disease in the pituitary gland or previous pituitary surgery\n* Any other disease\u002Fcondition which the trial managers believe may affect participation in the trial","MALE","20 Years","50 Years",{"count":74,"type":75},20,"ESTIMATED","INTERVENTIONAL",[78],"NA","Investigating the effect of oxytocin on pancreatic endocrine functions by determining insulin and glucagon secretion within physiological ranges of plasma glucose.",[81],"Glucose Metabolism Disorders (Including Diabetes Mellitus)",[83,84,85],"oxytocin","blood glucose","glucose stabilization","2024-04-02",{"date":88,"type":89},"2024-04-04","ACTUAL",{"date":91,"type":89},"2024-01-01",{"date":93,"type":75},"2026-12-31",{"name":5,"class":6},1]